Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
HOLX Transcript
Hologic, Inc. (HOLX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Neutral9-9
Hologic, Inc. (HOLX) Q3 2025 Earnings Call Transcript
Unknown7-30
Hologic's earnings call presented mixed signals: strong product development and strategic initiatives, but lowered EPS guidance and reduced revenue expectations from China. The Q&A session highlighted management's confidence in future growth, especially in Breast Health and Endomag, but lacked clarity on tariff mitigation and Fusion test contributions. With a lowered EPS and China revenue, alongside optimistic guidance and strategic growth, the overall sentiment is neutral, indicating a balanced outlook for short-term stock movement.
Hologic at RBC Healthcare Conference: Strategic Growth Amid Challenges
Neutral5-20
Hologic, Inc. (HOLX) Q2 2025 Earnings Call Transcript
Unknown5-1
The earnings call summary and Q&A highlight mixed results: stable earnings and revenue growth in diagnostics and surgical segments, but declines in breast health and lowered revenue guidance. While strong cash flow and share repurchases are positives, the lack of clarity on supply chain and competitive strategies, coupled with lower guidance, tempers optimism. The absence of new partnerships or strong guidance, and the uncertainty in China and Africa, suggest a neutral stock price movement.
HOLX Slides
HOLX Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
